Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine versus ethosuximide in children with absence epilepsy
IRCT20200115046137N3Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in absence epilepsy comparing Lamotrigine with Ethosuximide (2 arms). Primary endpoint: Effect of drugs on seizures in children with absence epilepsy. Started Mar 2022; status: completed.
02
Drugs
lamotrigineethosuximide
03
Conditions
absence epilepsy
Beyond the preview
Go deeper on IRCT20200115046137N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200115046137N3.